An outbreak of mumps in a population partially vaccinated with the Rubini strain
Publisher DOI
PubMed ID
8863352
Abstract
Since 1991, 6 years after the recommendation of universal childhood triple vaccination against measles, mumps and rubella (M + M + R), Switzerland has been confronted with an increasing number of mumps cases affecting both vaccinated and unvaccinated children. The M + M + R vaccine mainly used in the Swiss population after 1986 contains the highly attenuated Rubini strain of mumps virus. We analysed an outbreak of 102 suspected mumps cases by virus isolation, determination of IgM antibodies to mumps virus in 27 acute phase sera, and verification of vaccination histories. Mumps was confirmed by virus isolation in 88 patients, of whom 72 had previously received the Rubini vaccine strain. IgM antibodies to mumps virus were detected in 24/27 acute phase serum samples. A group of 92 subjects from the same geographic area without signs of mumps virus infection served as controls. IgG antibodies to mumps virus and vaccination status were assessed in these children. The vaccination rate in these controls was 61%, with equal seropositivity for unvaccinated and Rubini-vaccinated subjects. These data support other recent reports which indicate an insufficient protective efficacy of current mumps vaccines.
Date Issued
1996
Publication Type
Article
Language(s)
en
Author(s)
Germann, D | |
Ströhle, A | |
Eggenberger, K | |
Matter, L |
Additional Credits
Journal
Scandinavian journal of infectious diseases
Publisher
Informa Healthcare
ISSN
0036-5548
Access(Rights)
metadata.only